UBS analyst Andrea Alfonso raised the firm’s price target on Elanco (ELAN) to $27 from $25 and keeps a Buy rating on the shares. While there was plenty to like about the Q3 report, expectations are “fairly” lofty, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELAN:
- Elanco Animal Health Reports Strong Q3 2025 Results
- Elanco’s Q3 2025 Earnings Call Highlights Strong Growth
- Elanco Animal Health: Promising Growth and Margin Expansion Justify Buy Rating
- Elanco price target raised to $27 from $23 at Stifel
- Elanco Animal Health: Strong U.S. Performance and Innovative Portfolio Drive Buy Rating